Obesity Status and Sex Affect Eating Behavior in Patients With NAFLD
Researchers examined what factors affect eating behaviors in patients with nonalcoholic fatty liver disease.
Metabolic Liver Disease
METABOLIC LIVER DISEASE
Latest Articles
FDA Fast Tracks Ervogastat/Clesacostat for Nonalcoholic Steatohepatitis
Ervogastat is a diacylglycerol O-acyltransferase 2 inhibitor and clesacostat is an acetyl-CoA carboxylase inhibitor.
DASH Diet May Be Protective of Incident Nonalcoholic Fatty Liver Disease Risk
Researchers investigated whether adherence to specific diets were associated with changes in liver fat or incident nonalcoholic fatty liver disease.
Cardiovascular Disease Higher Among Lean Patients With Nonalcoholic Fatty Liver Disease
Researchers sought to determine the prevalence of cardiovascular disease, cirrhosis, metabolic diseases, and chronic kidney disease in lean vs overweight or obese NAFLD.
Safety and Efficacy of Aldafermin for the Treatment of Nonalcoholic Steatohepatitis
Researchers sought to determine the safety and efficacy of aldafermin among patients with nonalcoholic steatohepatitis.
NAFLD Associated With Long-Term Risk for Extrahepatic Cancers
Using a systematic review and meta-analysis, researchers investigated the association between NAFLD and the risk for developing extrahepatic cancers.
Bidirectional Association Identified for NAFLD and Psoriasis
There is a bidirectional association between nonalcoholic fatty liver disease (NAFLD) and psoriasis, especially for patients younger than 40 years.
Statin Initiation Reduces Risk for Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
Researchers examined the association between initiating statin therapy and the risk for HCC in patients with NAFLD.
Metabolic Dysfunction-Related Fatty Liver Disease Increases Risk for Colon Cancer
Researchers analyzed the relationship between metabolic dysfunction-associated fatty liver disease and the risk for colon cancer.
Increased Physical Activity May Reduce Risk for NAFLD
Investigators assessed the effects of different levels of physical activity on the prevalence of nonalcoholic fatty liver disease and its association with metabolic health.
Statin Use May Decrease Cancer-Related Mortality in Nonalcoholic Fatty Liver Disease
Researchers evaluated the effects of statin use on cancer mortality in patients with nonalcoholic fatty liver disease.
NAFLD May Raise Risk for Severe Hypoglycemia in Type 2 Diabetes
Nonalcoholic fatty liver disease (NAFLD) is associated with a higher risk for severe hypoglycemia in patients with type 2 diabetes.
Women With Long, Irregular Menstrual Cycles At Increased Risk For NAFLD
For young premenopausal women, long or irregular menstrual cycles are associated with an increased risk for both prevalent and incident NAFLD.
Efficacy of Antihyperglycemic Drugs for the Treatment of NAFLD and NASH
Investigators examined the effects of certain antihyperglycemic drugs as treatment for NAFLD or NASH in patients with or without type 2 diabetes.
Lean Patients at Similar Risk for Poor Outcomes, Mortality as Patients Classified As Non-Lean With NAFLD
Investigators assessed baseline characteristics and long-term outcomes of White patients classified as lean with nonalcoholic fatty liver disease.
DMR Significantly Improves Glycemic Control and Reduces Liver Fat Content in T2D
Investigators assessed the efficacy and safety of duodenal mucosal resurfacing vs a sham endoscopic procedure in patients with type 2 diabetes with or without NAFLD.
Psychotherapy May Help Sleep Apnea, Obesity, and NAFLD
Nonalcoholic fatty liver disease often has several systemic comorbities, including obstructive sleep apnea. Researchers explored a psychological link between them.
Intermittent Fasting Effective for Weight Loss in Adults With Obesity
Intermittent fasting has demonstrated health benefits in a number of randomized clinical trials. Researchers sough to directly link specific health outcomes from these trials in people with overweight or obesity.
Assessment and Treatment of Dietary and Mental Health Concerns in Youth With NAFLD
Investigators assessed the presence of unhealthy eating behaviors in adolescents with obesity undergoing bariatric surgery, with or without nonalcoholic fatty liver disease.
Fibrosis Stages F3 and F4 Associated With Higher Mortality Rate in NAFLD
Investigators assessed the incidence of mortality and other clinical outcomes among patients with various histologic stages of nonalcoholic fatty liver disease.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Loading... 
Loading...